SHAWLAWN FREEMAN-HICKS: Open Payments
NPI 1598305906 · NORTH CHESTERFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,062 in 123 payments from 17 companies in 2025. Trend: 2023 $425 · 2024 $376 · 2025 $3,062
Food & beverage: $3,062
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $492 |
| Alkermes, Inc. | 12 | $397 |
| Neurocrine BioSciences, Inc. | 11 | $353 |
| Lundbeck LLC | 17 | $320 |
| Otsuka America Pharmaceutical, Inc. | 13 | $312 |
| Vanda Pharmaceuticals Inc. | 10 | $290 |
| ABBVIE INC. | 15 | $218 |
| Axsome Therapeutics, Inc. | 4 | $197 |
| Janssen Pharmaceuticals, Inc | 3 | $96 |
| Teva Pharmaceuticals USA, Inc. | 5 | $91 |
Products named: CAPLYTA, ARISTADA, INGREZZA, REXULTI, FANAPT, VRAYLAR, Auvelity, ABILIFY ASIMTUFII.
Industry payments across VA — which companies pay providers there.
